Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1556-1558

  Aslam, Saima ^a,b   Trautner, Barbara W ^a,b   Ramanathan, Venkat ^a,b   Darouiche, Rabih O ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; SODIUM CHLORIDE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; CATHETER INFECTION; COLONY FORMING UNIT; CULTURE MEDIUM; DRUG EFFECT; DRUG POTENTIATION; INTRAVASCULAR CATHETER; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRASOUND;

ACETYLCYSTEINE; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; EQUIPMENT CONTAMINATION; MINOCYCLINE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 34247103735     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00893-06     Document Type: Article

References (27)

1. Curtin, J., M. Cormican, G. Fleming, J. Keelehan, and E. Colleran. 2003. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob. Agents Chemother. 47:3145-3148.
2. Darouiche, R. O. 2001. Device-associated infections: a macroproblem that starts with microadherence. Clin. Infect. Dis. 33:1567-1572.
3. Darouiche, R. O., A. Dhir, A. J. Miller, G. C. Landon, I. I. Raad, and D. M. Musher. 1994. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J. Infect. Dis. 170:720-723.
4. Digiovine, B., C. Chenoweth, C. Watts, and M. Higgins. 1999. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am. J. Respir. Crit. Care Med. 160:976-981.
5. El-Azizi, M., S. Rao, T. Kanchanapoom, and N. Khardori. 2005. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann. Clin. Microbiol. Antimicrob. 4:2.
6. Kao, L. W., M. A. Kirk, R. B. Furbee, N. H. Mehta, J. R. Skinner, and E. J. Brizendine. 2003. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? Ann. Emerg. Med. 42:741-750.
7. Krishnasami, Z., D. Carlton, L. Bimbo, M. E. Taylor, D. F. Balkovetz, J. Barker, and M. Allon. 2002. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 61:1136-1142.
8. Labthavikul, P., P. J. Petersen, and P. A. Bradford. 2003. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob. Agents Chemother. 47:3967-3969.
9. Marchese, A., M. Bozzolasco, L. Gualco, E. A. Debbia, G. C. Schito, and A. M. Schito. 2003. Effect of fosfomycin alone and in combination with N-acerylcysteine on E. coli biofilms. Int. J. Antimicrob. Agents 22(Suppl. 2):95-100.
10. Marr, K. A., D. J. Sexton, P. J. Conlon, G. R. Corey, S. J. Schwab, and K. B. Kirkland. 1997. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann. Intern. Med. 127:275-280.
11. Marzullo, L. 2005. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr. Opin. Pediatr. 17:239-245.
12. Mermel, L. A., B. M. Farr, R. J. Sherertz, I. I. Raad, N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:1249-1272.
13. Oldemeyer, J. B., W. P. Biddle, R. L. Wurdeman, A. N. Mooss, E. Cichowski, and D. E. Hilleman. 2003. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Am. Heart J. 146:E23.
14. Olofsson, A. C., M. Hermansson, and H. Elwing. 2003. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl. Environ. Microbiol. 69:4814-4822.
15. Pérez-Giraldo, C., A. Rodriguez-Benito, F. J. Moran, C. Hurtado, M. T. Blanco, and A. C. Gomez-Garcia. 1997. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J. Antimicrob. Chemother. 39:643-646.
16. Pittet, D., D. Tarara, and R. P. Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601.
17. Poole, C. V., D. Carlton, L. Bimbo, and M. Allon. 2004. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol. Dial. Transplant. 19:1237-1244.
18. Raad, I., I. Chatzinikolaou, G. Chaiban, H. Hanna, R. Hachem, T. Dvorak, G. Cook, and W. Costerton. 2003. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob. Agents Chemother. 47:3580-3585.
19. Rijnders, B. J., E. Van Wijngaerden, S. J. Vandecasteele, M. Stas, and W. E. Peetermans. 2005. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J. Antimicrob. Chemother. 55:90-94.
20. Schwandt, L. Q., R. Van Weissenbruch, I. Stokroos, H. C. Van der Mei, H. J. Busscher, and F. W. Albers. 2004. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 124:726-731.
21. Shah, C. B., M. W. Mittelman, J. W. Costerton, S. Parenteau, M. Pelak, R. Arsenault, and L. A. Mermel. 2002. Antimicrobial activity of a novel catheter lock solution. Antimicrob. Agents Chemother. 46:1674-1679.
22. Sherertz, R. J., M. S. Boger, C. A. Collins, L. Mason, and I. I. Raad. 2006. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob. Agents Chemother. 50:1865-1868.
23. Smith, R. L., S. M. Meixler, and M. S. Simberkoff. 1991. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100:164-167.
24. Trautner, B. W., and R. O. Darouiche. 2004. Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. 164:842-850.
25. Vercaigne, L. M., S. A. Zelenitsky, I. Findlay, K. Bernstein, and S. B. Penner. 2002. An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters. J. Antimicrob. Chemother. 49:693-696.
26. Wiederhold, N. P., E. A. Coyle, I. I. Raad, R. A. Prince, and R. E. Lewis. 2005. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J. Antimicrob. Chemother. 55:792-795.
27. Yip, L., R. C. Dart, and K. M. Hurlbut. 1998. Intravenous administration of oral N-acetylcysteine. Crit. Care Med. 26:40-43.